70Indexed trials
Market Rank #36 · Evidence Tier A
Romania
Neuroscience Intelligence
Romania neuroscience intelligence: 70 indexed trials, 18 institutions, research score 31.06.
16Recruiting
18Research institutions
31.1Research score
Evidence profile
45Sponsors
17Disease areas
0Institution works
0Institution citations
Evidence signals
Research score 31.1 · Data confidence 100.00 · Evidence 31.1
Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.
Leading disease areas
epilepsy14trials
parkinsons10trials
alzheimers9trials
multiple_sclerosis8trials
schizophrenia5trials
stroke4trials
neuromuscular3trials
neurodevelopmental_other3trials
other_neurology3trials
depression2trials
Leading indexed sponsors
Hoffmann-La Roche5trials
Boehringer Ingelheim4trials
Merck Sharp & Dohme LLC3trials
Eli Lilly and Company3trials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3trials
UCB Pharma3trials
Novartis2trials
Celgene2trials
Bristol-Myers Squibb2trials
Eisai Limited2trials